General Information of Drug Transporter (DT)
DT ID DTD0510 Transporter Info
Gene Name KCNH2
Transporter Name Voltage-gated potassium channel Kv11.1
Gene ID
3757
UniProt ID
Q12809
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Mycotoxins

  Aflatoxin B1

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Aflatoxin B1 results in decreased methylation of KCNH2 intron [126]

Regulation Mechanism

Transcription Factor Info

  aflatoxin B2

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

aflatoxin B2 results in increased methylation of KCNH2 intron [126]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

aflatoxin B2 results in increased methylation of KCNH2 polyA tail [126]

Regulation Mechanism

Transcription Factor Info

Pesticide/Insecticide

  DDT

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

DDT results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

Approved Drug

  Maraviroc

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Maraviroc inhibits the transportation of Dofetilide by KCNH2 [4]

Affected Drug/Substrate

Dofetilide Modulation Type Inhibition

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  DT Modulation2

Maraviroc inhibits the activity of KCNH2 [5]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Pimozide

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pimozide inhibits the activity of KCNH2 [6]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Thioridazine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Thioridazine inhibits the activity of KCNH2 [6]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Bepridil

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bepridil inhibits the activity of KCNH2 [6], [7]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Haloperidol

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Haloperidol inhibits the activity of KCNH2 [6], [8]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Dofetilide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dofetilide inhibits the activity of KCNH2 [7]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Clozapine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clozapine inhibits the activity of KCNH2 [7], [8], [9]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Risperidone

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Risperidone inhibits the activity of KCNH2 [8]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Aripiprazole

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Aripiprazole inhibits the activity of KCNH2 [8], [9]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Olanzapine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Olanzapine inhibits the activity of KCNH2 [8], [9]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Mizolastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mizolastine inhibits the activity of KCNH2 [10]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Fexofenadine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fexofenadine inhibits the activity of KCNH2 [2]

  Erythromycin

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Erythromycin inhibits the activity of KCNH2 [11], [12]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Quinine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Quinine inhibits the activity of KCNH2 [13]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Rofecoxib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rofecoxib inhibits the activity of KCNH2 [13]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Tegaserod

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tegaserod inhibits the activity of KCNH2 [14], [15]

Cell System

Chinese hamster ovary (CHO) cells-KCNH2

  Levofloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Levofloxacin inhibits the activity of KCNH2 [16]

Cell System

Chinese hamster ovary (CHO) cells-KCNH2

  Moxifloxacin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Moxifloxacin inhibits the activity of KCNH2 [16]

Cell System

Chinese hamster ovary (CHO) cells-KCNH2

  Chloroquine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chloroquine inhibits the activity of KCNH2 [17]

Cell System

Chinese hamster ovary (CHO) cells-KCNH2

  Halofantrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Halofantrine inhibits the activity of KCNH2 [17]

Cell System

Chinese hamster ovary (CHO) cells-KCNH2

  Cisapride

           7 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cisapride inhibits the activity of KCNH2 [18]

Cell System

Chinese hamster ovary (CHO) cells-KCNH2

  Pentobarbital

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pentobarbital inhibits the activity of KCNH2 [32]

  Probucol

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Probucol inhibits the activity of KCNH2 [33]

  Dronedarone

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dronedarone inhibits the activity of KCNH2 [34]

  Metoclopramide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Metoclopramide inhibits the activity of KCNH2 [35]

  Gabapentin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Gabapentin inhibits the activity of KCNH2 [36]

  Lamotrigine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lamotrigine inhibits the activity of KCNH2 [36]

  Topiramate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Topiramate inhibits the activity of KCNH2 [36]

  Carmustine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Carmustine inhibits the expression of KCNH2 [37]

  Lovastatin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lovastatin affects the activity of KCNH2 [38]

  Metoprolol

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Metoprolol inhibits the activity of KCNH2 [39]

  Mesoridazine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mesoridazine inhibits the activity of KCNH2 [40]

  Dipyridamole

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dipyridamole inhibits the activity of KCNH2 [41]

  Ketoconazole

         12 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ketoconazole inhibits the activity of KCNH2 [42]

  Arsenic

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Arsenic affects the expression of KCNH2 [43]

  Codeine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Codeine inhibits the activity of KCNH2 [44]

  Dextromethorphan

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dextromethorphan inhibits the activity of KCNH2 [44]

  Hydroxyzine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Hydroxyzine inhibits the activity of KCNH2 [45]

  Digoxin

           6 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Digoxin inhibits the expression of KCNH2 [46]

  Ouabain

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ouabain inhibits the expression of KCNH2 [46]

  Chlorpheniramine

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chlorpheniramine inhibits the activity of KCNH2 [47]

  Dalfampridine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dalfampridine inhibits the activity of KCNH2 [48]

  Amantadine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amantadine inhibits the activity of KCNH2 [49]

  Grepafloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Grepafloxacin inhibits the activity of KCNH2 [49]

  Venlafaxine Hydrochloride

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Venlafaxine Hydrochloride inhibits the activity of KCNH2 [49]

  Econazole

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Econazole inhibits the activity of KCNH2 [50]

  Calcitriol

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Calcitriol increases the expression of KCNH2 [51]

  Testosterone

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Testosterone increases the expression of KCNH2 [51]

  Arsenic Trioxide

         16 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Arsenic Trioxide inhibits the expression of KCNH2 [52]

  Crizotinib

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Crizotinib inhibits the activity of KCNH2 [53]

  Clarithromycin

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clarithromycin inhibits the activity of KCNH2 [54]

  Flecainide

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Flecainide inhibits the activity of KCNH2 [54]

  Fluvoxamine

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fluvoxamine inhibits the activity of KCNH2 [54]

  Glyburide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Glyburide inhibits the activity of KCNH2 [54]

  Idarubicin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Idarubicin inhibits the activity of KCNH2 [54]

  Imipramine

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Imipramine inhibits the activity of KCNH2 [54]

  Lidocaine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lidocaine inhibits the activity of KCNH2 [54]

  Mexiletine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mexiletine inhibits the activity of KCNH2 [54]

  Phentolamine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phentolamine inhibits the activity of KCNH2 [54]

  Ranolazine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ranolazine inhibits the activity of KCNH2 [54]

  Tacrine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tacrine inhibits the activity of KCNH2 [54]

  Tolcapone

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tolcapone inhibits the activity of KCNH2 [54]

  Cisplatin

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cisplatin inhibits the expression of KCNH2 [55]

  Azelastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Azelastine inhibits the activity of KCNH2 [56]

  Benzatropine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzatropine inhibits the activity of KCNH2 [56]

  Cefotetan

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cefotetan inhibits the activity of KCNH2 [56]

  Cepharanthine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cepharanthine inhibits the activity of KCNH2 [56]

  Chlorprothixene

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chlorprothixene inhibits the activity of KCNH2 [56]

  Clemastine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clemastine inhibits the activity of KCNH2 [56]

  Clofazimine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clofazimine inhibits the activity of KCNH2 [56]

  Clotrimazole

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clotrimazole inhibits the activity of KCNH2 [56]

  Diphenylpyraline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Diphenylpyraline inhibits the activity of KCNH2 [56]

  Duloxetine Hydrochloride

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Duloxetine Hydrochloride inhibits the activity of KCNH2 [56]

  Dutasteride

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dutasteride inhibits the activity of KCNH2 [56]

  Eletriptan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Eletriptan inhibits the activity of KCNH2 [56]

  Epinastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Epinastine inhibits the activity of KCNH2 [56]

  Fentanyl

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fentanyl inhibits the activity of KCNH2 [56]

  Fluorescein

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fluorescein inhibits the activity of KCNH2 [56]

  Flurazepam

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Flurazepam inhibits the activity of KCNH2 [56]

  Miconazole

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Miconazole inhibits the activity of KCNH2 [56]

  Oxiconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Oxiconazole inhibits the activity of KCNH2 [56]

  Palonosetron

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Palonosetron inhibits the activity of KCNH2 [56]

  Perphenazine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Perphenazine inhibits the activity of KCNH2 [56]

  Promazine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Promazine inhibits the activity of KCNH2 [56]

  Pyrithione zinc

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pyrithione zinc inhibits the activity of KCNH2 [56]

  Quetiapine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Quetiapine inhibits the activity of KCNH2 [56]

  Rescinnamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rescinnamine inhibits the activity of KCNH2 [56]

  Rosuvastatin Calcium

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rosuvastatin Calcium inhibits the activity of KCNH2 [56]

  Rotigotine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rotigotine inhibits the activity of KCNH2 [56]

  Salmeterol Xinafoate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Salmeterol Xinafoate inhibits the activity of KCNH2 [56]

  Semaxanib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Semaxanib inhibits the activity of KCNH2 [56]

  Sertraline

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sertraline inhibits the activity of KCNH2 [56]

  Sorafenib

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sorafenib inhibits the activity of KCNH2 [56]

  Tazarotene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tazarotene inhibits the activity of KCNH2 [56]

  Terconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Terconazole inhibits the activity of KCNH2 [56]

  Toremifene

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Toremifene inhibits the activity of KCNH2 [56]

  Triclabendazole

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Triclabendazole inhibits the activity of KCNH2 [56]

  Triflupromazine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Triflupromazine inhibits the activity of KCNH2 [56]

  Triprolidine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Triprolidine inhibits the activity of KCNH2 [56]

  Ziprasidone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ziprasidone inhibits the activity of KCNH2 [56]

  Erlotinib Hydrochloride

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Erlotinib Hydrochloride inhibits the activity of KCNH2 [57]

  Fluoxetine

           7 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fluoxetine inhibits the expression of KCNH2 [57]

  Imatinib Mesylate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Imatinib Mesylate inhibits the activity of KCNH2 [57]

  Nilotinib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nilotinib inhibits the expression of KCNH2 [57]

  Vandetanib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vandetanib inhibits the expression of KCNH2 [57]

  Amiodarone

           8 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amiodarone inhibits the activity of KCNH2 [54]

  Loratadine

           8 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Loratadine inhibits the activity of KCNH2 [58]

  Carvedilol

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Carvedilol inhibits the activity of KCNH2 [39]

  Quinidine

         13 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Quinidine inhibits the activity of KCNH2 [56]

  Chlorpromazine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chlorpromazine inhibits the activity of KCNH2 [54]

  Verapamil

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Verapamil inhibits the activity of KCNH2 [59]

  Trazodone

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Trazodone inhibits the activity of KCNH2 [56]

  Tretinoin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tretinoin inhibits the expression of KCNH2 [60]

  Sotalol

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sotalol inhibits the activity of KCNH2 [59]

  Droperidol

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Droperidol inhibits the activity of KCNH2 [56]

  Disopyramide

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Disopyramide inhibits the activity of KCNH2 [56]

  Desipramine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Desipramine inhibits the activity of KCNH2 [54]

  Reserpine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Reserpine inhibits the activity of KCNH2 [56]

  Tamoxifen

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tamoxifen inhibits the activity of KCNH2 [56]

  Sunitinib

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sunitinib inhibits the activity of KCNH2 [54]

  Valproic Acid

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Valproic Acid increases the expression of KCNH2 [61]

  Nefazodone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nefazodone inhibits the activity of KCNH2 [56]

  Daunorubicin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Daunorubicin inhibits the expression of KCNH2 [62]

  Mitoxantrone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mitoxantrone inhibits the expression of KCNH2 [62]

  Doxorubicin

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Doxorubicin inhibits the expression of KCNH2 [63]

  Desloratadine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Desloratadine inhibits the activity of KCNH2 [58]

  Ciprofloxacin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ciprofloxacin inhibits the activity of KCNH2 [64], [65]

  Linagliptin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Linagliptin inhibits the activity of KCNH2 [66]

  Betrixaban

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Betrixaban inhibits the activity of KCNH2 [67]

  Bicalutamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bicalutamide inhibits the activity of KCNH2 [68]

  Ximelegatran

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ximelegatran inhibits the activity of KCNH2 [69]

  Gemifloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Gemifloxacin inhibits the activity of KCNH2 [65]

  Linezolid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Linezolid inhibits the activity of KCNH2 [65]

  Vancomycin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vancomycin inhibits the activity of KCNH2 [65]

  Vorinostat

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vorinostat inhibits the activity of KCNH2 [70]

  Propafenone

           6 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Propafenone inhibits the activity of KCNH2 [71]

  Modafinil

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Modafinil inhibits the activity of KCNH2 [72]

  Phenytoin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phenytoin inhibits the activity of KCNH2 [73]

  Mefloquine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mefloquine inhibits the activity of KCNH2 [74]

  Pentamidine

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pentamidine inhibits the activity of KCNH2 [75]

Drug Marketed but not Approved by US FDA

  Rotenone

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rotenone inhibits the activity of KCNH2 [54]

  Ebastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ebastine inhibits the activity of KCNH2 [56]

  Profenamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Profenamine inhibits the activity of KCNH2 [56]

  Thonzonium bromide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Thonzonium bromide inhibits the activity of KCNH2 [56]

Drug in Phase 4 Trial

  Dihydrotestosterone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dihydrotestosterone inhibits the activity of KCNH2 [96]

Drug in Phase 3 Trial

  Volinanserin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Volinanserin inhibits the activity of KCNH2 [19], [20]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Litoxetine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Litoxetine inhibits the activity of KCNH2 [27]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  BMS-927711

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

BMS-927711 inhibits the activity of KCNH2 [28]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Tramiprosate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tramiprosate inhibits the activity of KCNH2 [29]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Vitamin E

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vitamin E increases the expression of KCNH2 [83]

  Curcumin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Curcumin inhibits the activity of KCNH2 [56]

  Manidipine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Manidipine inhibits the activity of KCNH2 [56]

  Domperidone

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Domperidone inhibits the activity of KCNH2 [56]

  Fasudil

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fasudil inhibits the activity of KCNH2 [101], [69]

  NVP-LAQ824

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NVP-LAQ824 inhibits the activity of KCNH2 [70]

  MK-3102

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

MK-3102 inhibits the activity of KCNH2 [112]

  BAF312

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

BAF312 inhibits the activity of KCNH2 [113]

  Bardoxolone methyl

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bardoxolone methyl inhibits the activity of KCNH2 [117]

Drug in Phase 2 Trial

  Staurosporine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Staurosporine inhibits the transportation of Astemizole by KCNH2 [1]

Affected Drug/Substrate

Astemizole Modulation Type Inhibition

  PF-00734200

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

PF-00734200 inhibits the activity of KCNH2 [26]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  TD-5108

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

TD-5108 inhibits the activity of KCNH2 [15]

Cell System

Chinese hamster ovary (CHO) cells-KCNH2

  AR9281

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

AR9281 inhibits the activity of KCNH2 [30]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  HP-184

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

HP-184 blocks the activity of KCNH2 [92]

  BMS-582949

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

BMS-582949 inhibits the activity of KCNH2 [103]

  MGCD-0103

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

MGCD-0103 inhibits the activity of KCNH2 [70]

  PDX-101

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

PDX-101 inhibits the activity of KCNH2 [70]

  MS-275

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

SNDX-275 inhibits the activity of KCNH2 [70]

  PF-03715455

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

PF-03715455 inhibits the activity of KCNH2 [107]

  Piboserod

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Piboserod inhibits the activity of KCNH2 [109]

  PF-3893787

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

PF-3893787 inhibits the activity of KCNH2 [110]

  GSK239512

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GSK239512 inhibits the activity of KCNH2 [111]

  NVP-AUY922

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NVP-AUY922 inhibits the activity of KCNH2 [114]

  BMS-911543

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

BMS-911543 inhibits the activity of KCNH2 [115]

Drug in Phase 1/2 Trial

  CX-4945

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CX-4945 inhibits the activity of KCNH2 [106]

  CEP-32496

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CEP-32496 inhibits the activity of KCNH2 [108]

Drug in Phase 1 Trial

  Mibefradil

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mibefradil inhibits the activity of KCNH2 [7]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Radiprodil

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Radiprodil inhibits the activity of KCNH2 [31]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  2-deoxyglucose

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

2-deoxyglucose inhibits the activity of KCNH2 [76]

  Adenosine Triphosphate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Adenosine Triphosphate inhibits the activity of KCNH2 [76]

  Geldanamycin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Geldanamycin inhibits the expression of KCNH2 [77]

  AY-27,255

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

AY-27,255 inhibits the activity of KCNH2 [41]

  Beta-cyclodextrins

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Beta-cyclodextrins inhibits the activity of KCNH2 [80]

  Naringenin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Naringenin inhibits the activity of KCNH2 [81]

  Cibenzoline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cibenzoline inhibits the activity of KCNH2 [54]

  Trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Trichostatin A inhibits the expression of KCNH2 [85]

  Fingolimod Hydrochloride

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fingolimod Hydrochloride inhibits the activity of KCNH2 [86]

  Bromperidol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bromperidol inhibits the activity of KCNH2 [56]

  Clotiapine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clotiapine inhibits the activity of KCNH2 [56]

  Denopamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Denopamine inhibits the activity of KCNH2 [56]

  Fendiline

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fendiline inhibits the activity of KCNH2 [56]

  Ipriflavone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ipriflavone inhibits the activity of KCNH2 [56]

  KB-2796

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

KB-2796 inhibits the activity of KCNH2 [56]

  M-813

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

M-813 inhibits the activity of KCNH2 [56]

  MJ-13105

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

MJ-13105 inhibits the activity of KCNH2 [56]

  Pericyazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pericyazine inhibits the activity of KCNH2 [56]

  Pizotifen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pizotifen inhibits the activity of KCNH2 [56]

  Prenylamine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Prenylamine inhibits the activity of KCNH2 [56]

  Quinacrine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Quinacrine inhibits the activity of KCNH2 [56]

  Vincamine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vincamine inhibits the activity of KCNH2 [56]

  Retigabine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Retigabine affects the activity of KCNH2 [89]

  Ajmaline

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ajmaline inhibits the activity of KCNH2 [54]

  Sertindole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sertindole inhibits the activity of KCNH2 [54]

  Lidoflazine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lidoflazine inhibits the activity of KCNH2 [56]

  Benzethonium

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzethonium inhibits the activity of KCNH2 [54]

  Isoquine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Isoquine inhibits the activity of KCNH2 [93]

  Turofexorate isopropyl

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Turofexorate isopropyl inhibits the activity of KCNH2 [97]

  Temanogrel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Temanogrel inhibits the activity of KCNH2 [100]

  MK-7246

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

MK-7246 inhibits the activity of KCNH2 [105]

Drug in Preclinical Test

  Proadifen

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Proadifen inhibits the activity of KCNH2 [56]

Discontinued Drug

  Fananserin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fananserin inhibits the activity of KCNH2 [19]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  PRX-00023

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

PRX-00023 inhibits the activity of KCNH2 [21]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  PNU-282987

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

PNU-282987 inhibits the activity of KCNH2 [22]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  YM60828

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

YM60828 inhibits the activity of KCNH2 [23]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Ronacaleret

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ronacaleret inhibits the activity of KCNH2 [95]

  GSK163090

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GSK163090 inhibits the activity of KCNH2 [104]

Investigative Drug

  Cyclorgdfv

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyclorgdfv inhibits the activity of KCNH2 [21]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Diphenyl(Piperidin-4-Yl)Methanol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Diphenyl(Piperidin-4-Yl)Methanol inhibits the activity of KCNH2 [2]

  3,9-Dihydro-N-Desmethyl-N-Isopropylerythromycin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

3,9-Dihydro-N-Desmethyl-N-Isopropylerythromycin A inhibits the activity of KCNH2 [11]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Glucose

         10 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Glucose inhibits the activity of KCNH2 [76]

  Ginsenoside Rb1

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ginsenoside Rb1 affects the activity of KCNH2 [78]

  Cyamemazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyamemazine inhibits the activity of KCNH2 [82]

  Malachite green

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Malachite green inhibits the activity of KCNH2 [50]

  Aprindine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Aprindine inhibits the activity of KCNH2 [56]

  Bopindolol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bopindolol inhibits the activity of KCNH2 [56]

  Isoconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Isoconazole inhibits the activity of KCNH2 [56]

  1-(1-(2-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix)

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-(1-(2-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) inhibits the activity of KCNH2 [91]

  1-(1-(4-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix)

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-(1-(4-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) inhibits the activity of KCNH2 [91]

  1-(2-(2-(Difluoromethoxy)Phenyl)-1-Phenylethyl)Piperazine (Enantiomeric Mix)

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-(2-(2-(Difluoromethoxy)Phenyl)-1-Phenylethyl)Piperazine (Enantiomeric Mix) inhibits the activity of KCNH2 [91]

  Premafloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Premafloxacin inhibits the activity of KCNH2 [64]

  Triphenylmethanamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Triphenylmethanamine inhibits the activity of KCNH2 [94]

  PHA-666859

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

PHA-666859 inhibits the activity of KCNH2 [98]

  1-(2,3-Dichlorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix)

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-(2,3-Dichlorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) inhibits the activity of KCNH2 [99]

  1-(3-Chloro-4-Fluorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix)

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-(3-Chloro-4-Fluorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) inhibits the activity of KCNH2 [99]

  Nifevirocn

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nifevirocn inhibits the activity of KCNH2 [102]

  Acid-activated omeprazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acid-activated omeprazole inhibits the activity of KCNH2 [69]

  GSK189254A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GSK189254A inhibits the activity of KCNH2 [111]

  Saccharin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Saccharin inhibits the activity of KCNH2 [116]

Drug Withdrawn

  Terfenadine

         17 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Terfenadine inhibits the transportation of Astemizole by KCNH2 [1]

Affected Drug/Substrate

Astemizole Modulation Type Inhibition

  DT Modulation2

Terfenadine inhibits the activity of KCNH2 [2]

  DT Modulation3

Terfenadine inhibits the activity of KCNH2 [3]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Astemizole

         13 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Astemizole inhibits the activity of KCNH2 [7], [24], [25]

Cell System

Human embryonic kidney 293 cells (HEK293)-KCNH2

  Nimesulide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nimesulide inhibits the activity of KCNH2 [54]

  Zimeldine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Zimeldine inhibits the activity of KCNH2 [54]

  Benzydamine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzydamine inhibits the activity of KCNH2 [56]

  Flupenthixol

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Flupenthixol inhibits the activity of KCNH2 [56]

  Niguldipine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Niguldipine inhibits the activity of KCNH2 [56]

Natural Product

  Mitragynine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mitragynine inhibits the expression of KCNH2 [88]

  DT Modulation1

Curcumin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Particulate Matter

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Particulate Matter increases the expression of KCNH2 [90]

  Resveratrol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Resveratrol inhibits the reaction Arsenic Trioxide results in decreased activity of KCNH2 protein [136]

Regulation Mechanism

Transcription Factor Info

Acute Toxic Substance

  Mercury

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mercury increases the expression of KCNH2 [79]

  Strychnine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Strychnine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

Health and Environmental Toxicant

  Butyraldehyde

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Butyraldehyde increases the expression of KCNH2 [87]

Herbicide

  Atrazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Atrazine increases the expression of KCNH2 [84]

Chemical Compound

  DT Modulation1

2-(4-(2-(3,4-dichlorophenyl)ethyl)phenylamino)benzoic acid inhibits the reaction Terfenadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

beta-Cyclodextrins analog inhibits the reaction Terfenadine results in decreased activity of KCNH2 protein [80]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Chlorobutanol promotes the reaction Terfenadine binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Ciclopirox inhibits the reaction Terfenadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Hydrogen Peroxide inhibits the reaction Terfenadine results in decreased activity of KCNH2 protein mutant form [147]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Terfenadine binds to and results in decreased activity of KCNH2 protein [164]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Terfenadine binds to KCNH2 protein [144]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Terfenadine co-treated with dofetilide binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Terfenadine co-treated with ergotoxin, Centruroides noxius binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

Terfenadine co-treated with Fluvoxamine binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

Terfenadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

Terfenadine promotes the reaction Chlorobutanol binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation13

Terfenadine promotes the reaction Ketoconazole results in decreased activity of KCNH2 protein [190]

Regulation Mechanism

Transcription Factor Info

  DT Modulation14

Terfenadine results in decreased activity of KCNH2 protein [145]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Pimozide inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Pimozide results in decreased activity of KCNH2 protein [153]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Thioridazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Thioridazine results in decreased activity of KCNH2 protein [153]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Bepridil binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Bepridil inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Bepridil results in decreased activity of KCNH2 protein [153]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Haloperidol inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Haloperidol results in decreased activity of KCNH2 protein [153]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Clozapine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Risperidone inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Aripiprazole inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Aripiprazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Olanzapine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Olanzapine results in decreased activity of KCNH2 protein [169]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Erythromycin affects the reaction KCNH2 protein results in decreased susceptibility to Doxorubicin [180]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Erythromycin binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Erythromycin binds to KCNH2 protein [144]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Erythromycin results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

KCNH2 gene SNP affects the susceptibility to Quinine [210]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Quinine results in decreased activity of KCNH2 protein [210]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Moxifloxacin results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

beta-Cyclodextrins analog inhibits the reaction Cisapride results in decreased activity of KCNH2 protein [80]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Cisapride affects the localization of KCNH2 protein mutant form [142]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Cisapride binds to and results in decreased activity of KCNH2 protein [164]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Cisapride binds to KCNH2 protein [144]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Cisapride inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Cisapride results in decreased activity of KCNH2 protein [165]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Mibefradil inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Mibefradil results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Astemizole affects the localization of KCNH2 protein mutant form [142]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Astemizole binds to and results in decreased activity of KCNH2 protein [143]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Astemizole binds to KCNH2 gene polymorphism [144]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Astemizole binds to KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Astemizole inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Astemizole inhibits the reaction Digoxin results in decreased activity of KCNH2 protein [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Astemizole inhibits the reaction Digoxin results in decreased metabolism of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Astemizole inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Astemizole results in decreased activity of KCNH2 protein [145]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

dofetilide analog inhibits the reaction Astemizole binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

Hydrogen Peroxide inhibits the reaction Astemizole results in decreased activity of KCNH2 protein mutant form [147]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

Potassium promotes the reaction Astemizole binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Pentobarbital results in decreased activity of KCNH2 protein [32]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Probucol results in decreased activity of KCNH2 protein SNP [33]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Dronedarone results in decreased activity of KCNH2 protein [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Potassium inhibits the reaction Dronedarone results in decreased activity of KCNH2 protein [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Metoclopramide results in decreased activity of KCNH2 protein [35]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Gabapentin results in decreased activity of KCNH2 protein [36]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Lamotrigine results in decreased activity of KCNH2 protein [36]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Topiramate results in decreased activity of KCNH2 protein [36]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Lovastatin affects the activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Metoprolol results in decreased activity of KCNH2 protein [39]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Metoprolol results in decreased activity of KCNH2 protein binds to KCNH2 protein [188]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Mesoridazine results in decreased activity of KCNH2 protein [40]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Dipyridamole results in decreased activity of KCNH2 protein [41]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

KCNH2 protein mutant form results in decreased susceptibility to Ketoconazole [189]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Ketoconazole affects the activity of KCNH2 protein mutant form [42]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Ketoconazole affects the localization of KCNH2 [42]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Ketoconazole affects the localization of KCNH2 protein mutant form [42]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Ketoconazole binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Ketoconazole co-treated with desloratadine co-treated with Loratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Ketoconazole co-treated with desloratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Ketoconazole co-treated with Loratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Ketoconazole results in decreased activity of KCNH2 [42]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

Ketoconazole results in decreased activity of KCNH2 protein [189]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

Terfenadine promotes the reaction Ketoconazole results in decreased activity of KCNH2 protein [190]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Codeine results in decreased activity of KCNH2 protein [44]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Dextromethorphan results in decreased activity of KCNH2 protein [44]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Hydroxyzine results in decreased activity of KCNH2 protein [45]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Astemizole inhibits the reaction Digoxin results in decreased activity of KCNH2 protein [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Astemizole inhibits the reaction Digoxin results in decreased metabolism of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Digoxin results in decreased activity of KCNH2 protein [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

KCNH2 gene affects the susceptibility to Digoxin [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Sodium deficiency inhibits the reaction Digoxin results in decreased expression of KCNH2 protein [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Ouabain inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Ouabain results in decreased activity of KCNH2 protein [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Chlorpheniramine affects the activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Chlorpheniramine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Chlorpheniramine results in decreased activity of KCNH2 protein [47]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Amantadine results in decreased activity of KCNH2 protein [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Venlafaxine Hydrochloride results in decreased activity of KCNH2 protein [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Econazole results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Econazole results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Testosterone co-treated with Calcitriol results in increased expression of KCNH2 mRNA [51]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Testosterone co-treated with Calcitriol results in increased expression of KCNH2 mRNA [51]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Arsenic Trioxide affects the expression of and results in increased activity of KCNH2 protein [135]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Arsenic Trioxide results in decreased activity of KCNH2 protein [136]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Arsenic Trioxide results in decreased expression of and affects the localization of and results in decreased activity of KCNH2 protein [137]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Arsenic Trioxide results in decreased localization of KCNH2 protein [138]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Arsenic Trioxide results in increased expression of KCNH2 mRNA [140]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Astemizole inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

fexofenadine inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

Matrines inhibits the reaction Arsenic Trioxide results in decreased localization of KCNH2 protein [141]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

MIR21 mRNA promotes the reaction Arsenic Trioxide results in decreased expression of KCNH2 protein [137]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

MIR23A mRNA promotes the reaction Arsenic Trioxide results in decreased expression of and affects the localization of and results in decreased activity of KCNH2 protein [137]

Regulation Mechanism

Transcription Factor Info

  DT Modulation13

oxymatrine inhibits the reaction Arsenic Trioxide results in decreased localization of KCNH2 protein [141]

Regulation Mechanism

Transcription Factor Info

  DT Modulation14

Ranolazine inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation15

Resveratrol inhibits the reaction Arsenic Trioxide results in decreased activity of KCNH2 protein [136]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Crizotinib results in decreased activity of KCNH2 protein [53]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Clarithromycin results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

KCNE2 protein mutant form binds to KCNH2 protein which results in increased susceptibility to Clarithromycin [167]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Flecainide binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Flecainide results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Fluvoxamine binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Fluvoxamine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Fluvoxamine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Terfenadine co-treated with Fluvoxamine binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Glyburide results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Idarubicin results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Imipramine binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Imipramine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Imipramine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Lidocaine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Mexiletine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Phentolamine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Phentolamine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Ranolazine inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Ranolazine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Tacrine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Tolcapone results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Rotenone results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Cisplatin results in increased expression of KCNH2 [166]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

KCNH2 results in increased susceptibility to Cisplatin [166]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Cefotetan results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Chlorprothixene results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Clemastine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Clofazimine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Clotrimazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Duloxetine Hydrochloride results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Dutasteride results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Fentanyl results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Fluorescein results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Flurazepam results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Miconazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Palonosetron results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Perphenazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Perphenazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Promazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Rosuvastatin Calcium results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Salmeterol Xinafoate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Sertraline results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Sorafenib results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Toremifene results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Triclabendazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Triflupromazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Triprolidine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Erlotinib Hydrochloride affects the activity of KCNH2 protein [53]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Erlotinib Hydrochloride results in decreased activity of KCNH2 protein [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Fluoxetine affects the localization of KCNH2 protein [186]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Fluoxetine binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Fluoxetine inhibits the reaction KCNH2 protein results in increased transport of Potassium [187]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Fluoxetine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Fluoxetine results in decreased activity of KCNH2 protein [186]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

KCNH2 protein affects the susceptibility to Fluoxetine [186]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Imatinib Mesylate results in decreased activity of KCNH2 protein [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Amiodarone affects the activity of KCNH2 protein [129]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Amiodarone binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Amiodarone inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Amiodarone promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Amiodarone results in decreased activity of KCNH2 protein [132]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

naringenin promotes the reaction Amiodarone results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Potassium inhibits the reaction Amiodarone results in decreased activity of KCNH2 protein [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

desloratadine co-treated with Loratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Ketoconazole co-treated with desloratadine co-treated with Loratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Ketoconazole co-treated with Loratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Loratadine affects the activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Loratadine binds to and results in decreased activity of KCNH2 protein [191]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Loratadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Loratadine results in decreased activity of KCNH2 protein [192]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Carvedilol affects the activity of KCNH2 protein [129]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Carvedilol results in decreased activity of KCNH2 protein [157]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Acids inhibits the reaction Quinidine results in decreased activity of KCNH2 protein [149]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

KCNH2 gene mutant form results in decreased susceptibility to Quinidine [209]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

KCNH2 gene SNP affects the susceptibility to Quinidine [210]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

naringenin promotes the reaction Quinidine results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Potassium inhibits the reaction Quinidine results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Quinidine affects the activity of KCNH2 protein [129]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Quinidine affects the localization of KCNH2 protein mutant form [165]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Quinidine binds to KCNH2 protein [144]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Quinidine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

Quinidine promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

Quinidine results in decreased activity of KCNH2 protein [165]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

Quinidine results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Chlorpromazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Chlorpromazine results in decreased activity of KCNH2 protein [163]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Verapamil inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Verapamil results in decreased activity of KCNH2 protein [153]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Verapamil results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Trazodone results in decreased activity of KCNH2 protein [214]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

KCNH2 gene mutant form results in decreased susceptibility to Sotalol [209]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Potassium inhibits the reaction Sotalol results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Sotalol analog binds to KCNH2 protein [144]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Sotalol results in decreased activity of KCNH2 protein [181]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Droperidol inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Droperidol results in decreased activity of KCNH2 protein [181]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Disopyramide binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Disopyramide results in decreased activity of KCNH2 protein [177]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Desipramine results in decreased activity of KCNH2 protein [173]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Reserpine results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Reserpine results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Tamoxifen binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Tamoxifen inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Tamoxifen results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Tamoxifen results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Sunitinib results in decreased activity of KCNH2 protein [212]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Valproic Acid affects the expression of KCNH2 mRNA [215]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Valproic Acid results in increased methylation of KCNH2 gene [61]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Erythromycin affects the reaction KCNH2 protein results in decreased susceptibility to Doxorubicin [180]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

KCNH2 protein results in decreased susceptibility to Doxorubicin [180]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Ciprofloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Propafenone affects the activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Propafenone analog binds to and results in decreased activity of KCNH2 protein [207]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Propafenone binds to and results in decreased activity of KCNH2 protein [207]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Propafenone inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Propafenone results in decreased activity of KCNH2 protein [177]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Phenytoin results in decreased activity of KCNH2 protein [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Mefloquine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Mefloquine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Pentamidine affects the localization of and affects the activity of KCNH2 protein [203]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Pentamidine affects the localization of and results in decreased activity of KCNH2 protein [204]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Pentamidine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Pentamidine results in decreased activity of KCNH2 protein [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Adenosine Triphosphate deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

alpha-Tocopherol inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Deoxyglucose co-treated with Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Deoxyglucose inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Deoxyglucose promotes the reaction Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Pyruvic Acid inhibits the reaction Deoxyglucose co-treated with Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Sodium Cyanide inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Vitamin E inhibits the reaction TNF protein results in decreased activity of KCNH2 protein [194]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Zimeldine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Fingolimod Hydrochloride results in decreased activity of KCNH2 protein [86]

Regulation Mechanism

Transcription Factor Info

  Pentanal

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pentanal increases the expression of KCNH2 [87]

  DT Modulation1

Fendiline results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Prenylamine results in decreased activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Quinacrine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Vincamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Proadifen results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Aprindine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Benzydamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Flupenthixol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Ajmaline results in decreased activity of KCNH2 protein [127]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Domperidone inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Domperidone results in decreased activity of KCNH2 protein [35]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

KCNH2 gene SNP affects the susceptibility to Domperidone [179]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Lidoflazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Lidoflazine results in decreased activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Benzethonium results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Benzethonium results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  1,3-ditolylguanidine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1,3-ditolylguanidine results in decreased activity of KCNH2 protein [118]

Regulation Mechanism

Transcription Factor Info

  1-(5-fluoropentyl)-3-(1-naphthoyl)indole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-(5-fluoropentyl)-3-(1-naphthoyl)indole results in decreased activity of KCNH2 protein [119]

Regulation Mechanism

Transcription Factor Info

  18-methoxycoronaridine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

18-methoxycoronaridine results in decreased activity of KCNH2 protein [120]

Regulation Mechanism

Transcription Factor Info

  1-Methyl-3-isobutylxanthine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Colforsin co-treated with 1-Methyl-3-isobutylxanthine results in increased activity of ADRB1 protein binds to ADRB2 protein affects the reaction KCNH2 protein results in increased transport of Potassium [121]

Regulation Mechanism

Transcription Factor Info

  1-pentyl-3-(1-naphthoyl)indole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-pentyl-3-(1-naphthoyl)indole results in decreased activity of KCNH2 protein [119]

Regulation Mechanism

Transcription Factor Info

  2-(2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino)nicotinic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

2-(2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino)nicotinic acid results in increased activity of KCNH2 protein [122]

Regulation Mechanism

Transcription Factor Info

  3,3'-diethylthiacarbocyanine iodide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

3,3'-diethylthiacarbocyanine iodide results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  3,4,5,3',4'-pentachlorobiphenyl

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

3,4,5,3',4'-pentachlorobiphenyl affects the activity of KCNH2 protein [123]

Regulation Mechanism

Transcription Factor Info

  4-AcO-DET

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

4-AcO-DET results in decreased activity of KCNH2 protein [124]

Regulation Mechanism

Transcription Factor Info

  4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  4-Aminopyridine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

4-Aminopyridine results in decreased activity of KCNH2 protein [48]

Regulation Mechanism

Transcription Factor Info

  4-HO-MET

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

4-HO-MET results in decreased activity of KCNH2 protein [124]

Regulation Mechanism

Transcription Factor Info

  8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a)quinoxalin-5(6H)-one

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a)quinoxalin-5(6H)-one inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  9-(2-hydroxy-3-nonyl)adenine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

9-(2-hydroxy-3-nonyl)adenine results in decreased activity of KCNH2 protein [41]

Regulation Mechanism

Transcription Factor Info

  abrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

abrine results in decreased expression of KCNH2 mRNA [125]

Regulation Mechanism

Transcription Factor Info

  Aldehydes

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Aldehydes results in increased expression of KCNH2 mRNA [128]

Regulation Mechanism

Transcription Factor Info

  alinidine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

alinidine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  alpha-Tocopherol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

alpha-Tocopherol inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  alpidem

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

alpidem results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  alverine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

alverine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Amitriptyline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amitriptyline inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  amorolfine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

amorolfine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  amperozide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

amperozide inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  Amsacrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amsacrine binds to and results in decreased activity of KCNH2 protein [133]

Regulation Mechanism

Transcription Factor Info

  aprofen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

aprofen results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  aristolochic acid I

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

aristolochic acid I results in increased expression of KCNH2 mRNA [134]

Regulation Mechanism

Transcription Factor Info

  Azaperone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Azaperone results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  azaspiracid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

azaspiracid binds to and results in decreased activity of KCNH2 protein [148]

Regulation Mechanism

Transcription Factor Info

  azelastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

azelastine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  azimilide

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acids inhibits the reaction azimilide results in decreased activity of KCNH2 protein [149]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

azimilide promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

azimilide results in decreased activity of KCNH2 protein [149]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

naringenin promotes the reaction azimilide results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Potassium inhibits the reaction azimilide results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  balofloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

balofloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  Benactyzine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benactyzine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  benfluorex

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

benfluorex results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  benoxinate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

benoxinate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Benperidol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benperidol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Benzo(a)pyrene

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzo(a)pyrene affects the methylation of KCNH2 intron [126]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Benzo(a)pyrene affects the methylation of KCNH2 polyA tail [126]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Benzo(a)pyrene results in decreased methylation of KCNH2 3' UTR [152]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Benzo(a)pyrene results in decreased methylation of KCNH2 exon [152]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Benzo(a)pyrene results in increased methylation of KCNH2 promoter [152]

Regulation Mechanism

Transcription Factor Info

  benzo(e)pyrene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

benzo(e)pyrene results in increased methylation of KCNH2 intron [126]

Regulation Mechanism

Transcription Factor Info

  Benztropine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benztropine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  benzyloxycarbonylleucyl-leucyl-leucine aldehyde

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  beta-Cyclodextrins

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

beta-Cyclodextrins analog inhibits the reaction Cisapride results in decreased activity of KCNH2 protein [80]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

beta-Cyclodextrins analog inhibits the reaction E 4031 results in decreased activity of KCNH2 protein [80]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

beta-Cyclodextrins analog inhibits the reaction Terfenadine results in decreased activity of KCNH2 protein [80]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

beta-Cyclodextrins analog results in decreased activity of KCNH2 protein [80]

Regulation Mechanism

Transcription Factor Info

  Betahistine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Betahistine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  bifemelane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bifemelane results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  bisphenol A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol A results in decreased methylation of KCNH2 gene [154]

Regulation Mechanism

Transcription Factor Info

  bisphenol S

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol S co-treated with Fulvestrant results in decreased methylation of KCNH2 gene [154]

Regulation Mechanism

Transcription Factor Info

  bopindolol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bopindolol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Brefeldin A

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Brefeldin A promotes the reaction vandetanib results in decreased expression of KCNH2 protein modified form [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Brefeldin A results in decreased expression of KCNH2 protein modified form [57]

Regulation Mechanism

Transcription Factor Info

  Bromhexine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bromhexine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  bromocyclen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bromocyclen results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  bromperidol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bromperidol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Brompheniramine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Brompheniramine results in decreased activity of KCNH2 protein [155]

Regulation Mechanism

Transcription Factor Info

  bucindolol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bucindolol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  buclizine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

buclizine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  bunamidine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bunamidine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Butaclamol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Butaclamol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  butoconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

butoconazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  butyraldehyde

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

butyraldehyde results in increased expression of KCNH2 mRNA [87]

Regulation Mechanism

Transcription Factor Info

  camylofine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

camylofine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Carbachol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

KCNH2 protein mutant form affects the susceptibility to Carbachol [156]

Regulation Mechanism

Transcription Factor Info

  carbetapentane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

carbetapentane results in decreased activity of KCNH2 protein [44]

Regulation Mechanism

Transcription Factor Info

  carbinoxamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

carbinoxamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  cepharanthine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cepharanthine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  cetalkonium chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cetalkonium chloride results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  cetyldimethylethylammonium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cetyldimethylethylammonium results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  CGP 52608

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CGP 52608 promotes the reaction RORA protein binds to KCNH2 gene [158]

Regulation Mechanism

Transcription Factor Info

  chloramine-T

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

chloramine-T results in increased oxidation of and results in decreased activity of KCNH2 protein [159]

Regulation Mechanism

Transcription Factor Info

  Chlorobutanol

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chlorobutanol binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Chlorobutanol promotes the reaction Methadone results in decreased activity of KCNH2 protein [161]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Chlorobutanol promotes the reaction Terfenadine binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Chlorobutanol results in decreased activity of KCNH2 protein [161]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Terfenadine promotes the reaction Chlorobutanol binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  Chloroform

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chloroform results in decreased activity of KCNH2 protein [162]

Regulation Mechanism

Transcription Factor Info

  Ciclopirox

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ciclopirox inhibits the reaction Terfenadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Ciclopirox promotes the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  cifenline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cifenline results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  Cinacalcet

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cinacalcet results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  cinchonine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cinchonine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  clebopride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

clebopride results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  clobutinol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

clobutinol results in decreased activity of KCNH2 protein [44]

Regulation Mechanism

Transcription Factor Info

  clofedanol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

clofedanol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  clofexamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

clofexamide results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Clomipramine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clomipramine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  Clopenthixol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clopenthixol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  cloperastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cloperastine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  clothiapine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

clothiapine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  cobaltous chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cobaltous chloride results in decreased expression of KCNH2 mRNA [168]

Regulation Mechanism

Transcription Factor Info

  Colforsin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Colforsin co-treated with 1-Methyl-3-isobutylxanthine results in increased activity of ADRB1 protein binds to ADRB2 protein affects the reaction KCNH2 protein results in increased transport of Potassium [121]

Regulation Mechanism

Transcription Factor Info

  cyamemazine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cyamemazine metabolite results in decreased activity of KCNH2 protein [82]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

cyamemazine results in decreased activity of KCNH2 protein [169]

Regulation Mechanism

Transcription Factor Info

  cyamemazine sulfoxide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cyamemazine sulfoxide results in decreased activity of KCNH2 protein [82]

Regulation Mechanism

Transcription Factor Info

  Cyclosporine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyclosporine results in decreased methylation of KCNH2 promoter [170]

Regulation Mechanism

Transcription Factor Info

  cyclovirobuxine D

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cyclovirobuxine D results in decreased activity of KCNH2 protein [171]

Regulation Mechanism

Transcription Factor Info

  danofloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

danofloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  Dantrolene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dantrolene results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  danuglipron

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

danuglipron results in increased activity of KCNH2 protein [172]

Regulation Mechanism

Transcription Factor Info

  darifenacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

darifenacin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  decominol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

decominol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  denopamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

denopamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Deoxyglucose

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Deoxyglucose co-treated with Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Deoxyglucose inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Deoxyglucose promotes the reaction Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Deoxyglucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Pyruvic Acid inhibits the reaction Deoxyglucose co-treated with Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  desloratadine

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

desloratadine co-treated with Loratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

desloratadine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Ketoconazole co-treated with desloratadine co-treated with Loratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Ketoconazole co-treated with desloratadine results in decreased activity of KCNH2 protein [58]

Regulation Mechanism

Transcription Factor Info

  desmethylastemizole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

desmethylastemizole binds to and results in decreased activity of KCNH2 protein [143]

Regulation Mechanism

Transcription Factor Info

  dexbrompheniramine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

dexbrompheniramine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Dexetimide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dexetimide results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  diallyl trisulfide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

diallyl trisulfide results in decreased activity of KCNH2 protein [174]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

diallyl trisulfide results in decreased expression of and results in decreased activity of KCNH2 protein [175]

Regulation Mechanism

Transcription Factor Info

  diazoline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

diazoline results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  dibenzheptropine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

dibenzheptropine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Dibucaine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dibucaine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  didecyldimethylammonium

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

didecyldimethylammonium results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

didecyldimethylammonium results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  difloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

difloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  dimethisoquin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

dimethisoquin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  di-n-butylphosphoric acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

di-n-butylphosphoric acid affects the expression of KCNH2 mRNA [176]

Regulation Mechanism

Transcription Factor Info

  diphenylguanidine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

diphenylguanidine results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

diphenylguanidine results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  diphenylpyraline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

diphenylpyraline results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Dithiazanine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dithiazanine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Dobutamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dobutamine results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  dofetilide

         14 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acids inhibits the reaction dofetilide results in decreased activity of KCNH2 protein [149]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

dofetilide analog inhibits the reaction Astemizole binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

dofetilide analog inhibits the reaction dofetilide binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

dofetilide binds to and results in decreased activity of KCNH2 protein [178]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

dofetilide binds to KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

dofetilide inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

dofetilide promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

dofetilide results in decreased activity of KCNH2 protein [147]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Hydrogen Peroxide inhibits the reaction dofetilide results in decreased activity of KCNH2 protein mutant form [147]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

naringenin promotes the reaction dofetilide results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

Potassium affects the reaction dofetilide analog inhibits the reaction dofetilide binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

Potassium inhibits the reaction dofetilide results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  DT Modulation13

Potassium promotes the reaction dofetilide binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation14

Terfenadine co-treated with dofetilide binds to and results in decreased activity of KCNH2 protein [160]

Regulation Mechanism

Transcription Factor Info

  dolasetron

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

dolasetron results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  domiphen

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

domiphen results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

domiphen results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  Doxepin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Doxepin inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  dyclonine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

dyclonine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  E 4031

         13 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

beta-Cyclodextrins analog inhibits the reaction E 4031 results in decreased activity of KCNH2 protein [80]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

E 4031 affects the localization of KCNH2 protein mutant form [165]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

E 4031 binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

E 4031 binds to KCNH2 protein [182]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

E 4031 inhibits the reaction fexofenadine results in increased activity of KCNH2 protein mutant form [183]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

E 4031 inhibits the reaction Flufenamic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

E 4031 inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

E 4031 inhibits the reaction Niflumic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

E 4031 results in decreased activity of KCNE2 protein binds to KCNH2 protein [167]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

E 4031 results in decreased activity of KCNH2 protein [165]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

E 4031 results in increased activity of KCNH2 protein mutant form [142]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

E 4031 results in increased glycosylation of and affects the localization of KCNH2 protein mutant form [142]

Regulation Mechanism

Transcription Factor Info

  DT Modulation13

KCNE2 protein binds to KCNH2 protein which results in increased susceptibility to E 4031 [167]

Regulation Mechanism

Transcription Factor Info

  ebastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ebastine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  eburnamonine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

eburnamonine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  eletriptan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

eletriptan results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  eliprodil

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

eliprodil inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  emedastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

emedastine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  (endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

(endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide results in decreased activity of KCNH2 protein [185]

Regulation Mechanism

Transcription Factor Info

  Enoxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Enoxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  Enrofloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Enrofloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  epinastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

epinastine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  ethaverine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ethaverine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  ezogabine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ezogabine affects the activity of KCNH2 protein [89]

Regulation Mechanism

Transcription Factor Info

  fananserin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

fananserin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  febantel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

febantel results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  fenoverine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

fenoverine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  fexofenadine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

E 4031 inhibits the reaction fexofenadine results in increased activity of KCNH2 protein mutant form [183]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

fexofenadine inhibits the reaction Arsenic Trioxide results in increased degradation of KCNH2 protein [139]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

fexofenadine results in increased activity of KCNH2 protein mutant form [183]

Regulation Mechanism

Transcription Factor Info

  flazolone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

flazolone results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Fleroxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fleroxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  Flufenamic Acid

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

E 4031 inhibits the reaction Flufenamic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Flufenamic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  fomocain

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

fomocain results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Formoterol Fumarate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Formoterol Fumarate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Fulvestrant

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol S co-treated with Fulvestrant results in decreased methylation of KCNH2 gene [154]

Regulation Mechanism

Transcription Factor Info

  Gatifloxacin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Gatifloxacin binds to and results in decreased activity of KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Gatifloxacin binds to and results in decreased activity of KCNH2 protein which results in decreased export of Potassium [151]

Regulation Mechanism

Transcription Factor Info

  geldanamycin

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

geldanamycin affects the localization of KCNH2 protein [77]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

geldanamycin inhibits the reaction KCNH2 protein binds to HSP90AA1 protein [77]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

geldanamycin results in decreased activity of KCNH2 protein [77]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

geldanamycin results in decreased expression of KCNH2 protein modified form [77]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

geldanamycin results in increased degradation of KCNH2 protein [77]

Regulation Mechanism

Transcription Factor Info

  Gentian Violet

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Gentian Violet results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  ginsenoside Rb1

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ginsenoside Rb1 affects the activity of KCNH2 protein [78]

Regulation Mechanism

Transcription Factor Info

  ginsenoside Rf

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ginsenoside Rf affects the activity of KCNH2 protein [78]

Regulation Mechanism

Transcription Factor Info

  ginsenoside Rg1

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ginsenoside Rg1 affects the activity of KCNH2 protein [78]

Regulation Mechanism

Transcription Factor Info

  GR 103691

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GR 103691 results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Gramicidin

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Gramicidin results in decreased expression of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Potassium inhibits the reaction Gramicidin results in decreased expression of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Rubidium inhibits the reaction Gramicidin results in decreased expression of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  grepafloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

grepafloxacin results in decreased activity of KCNH2 protein [49]

Regulation Mechanism

Transcription Factor Info

  halofantrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

halofantrine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Hexetidine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Hexetidine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  homosalate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

homosalate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Hydrogen Peroxide

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Hydrogen Peroxide inhibits the reaction Astemizole results in decreased activity of KCNH2 protein mutant form [147]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Hydrogen Peroxide inhibits the reaction dofetilide results in decreased activity of KCNH2 protein mutant form [147]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Hydrogen Peroxide inhibits the reaction Terfenadine results in decreased activity of KCNH2 protein mutant form [147]

Regulation Mechanism

Transcription Factor Info

  Hydroxychloroquine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Hydroxychloroquine binds to and results in decreased activity of KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Hydroxychloroquine binds to and results in decreased activity of KCNH2 protein which results in decreased export of Potassium [151]

Regulation Mechanism

Transcription Factor Info

  Ibogaine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ibogaine results in decreased activity of KCNH2 protein [120]

Regulation Mechanism

Transcription Factor Info

  ICI 118551

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ICI 118551 results in decreased activity of KCNH2 protein [39]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

ICI 118551 results in decreased activity of KCNH2 protein binds to KCNH2 protein [188]

Regulation Mechanism

Transcription Factor Info

  ifenprodil

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ifenprodil results in decreased activity of KCNH2 protein [118]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

SM 21 promotes the reaction ifenprodil results in decreased activity of KCNH2 protein [118]

Regulation Mechanism

Transcription Factor Info

  Iofetamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Iofetamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  ipriflavone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ipriflavone results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  isamoltane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

isamoltane results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  isoconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

isoconazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Ivabradine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ivabradine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  JWH-073

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

JWH-073 results in decreased activity of KCNH2 protein [119]

Regulation Mechanism

Transcription Factor Info

  L 706000

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

L 706000 binds to and results in decreased activity of KCNH2 protein [164]

Regulation Mechanism

Transcription Factor Info

  lenperone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

lenperone results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  levomepromazine maleate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

levomepromazine maleate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  lifibrate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

lifibrate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  liranaftate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

liranaftate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Lobeline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lobeline results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Lofepramine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lofepramine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  lomefloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

lomefloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  lomerizine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

lomerizine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Loxapine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Loxapine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  lubeluzole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

lubeluzole binds to and results in decreased activity of KCNH2 protein [193]

Regulation Mechanism

Transcription Factor Info

  malachite green

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

malachite green results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

malachite green results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  manganese(III)-tetrakis(4-benzoic acid)porphyrin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction TNF protein results in decreased activity of KCNH2 protein [194]

Regulation Mechanism

Transcription Factor Info

  manidipine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

manidipine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Maprotiline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Maprotiline inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  mebeverine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

mebeverine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  mepazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

mepazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Methadone

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chlorobutanol promotes the reaction Methadone results in decreased activity of KCNH2 protein [161]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Methadone results in decreased activity of KCNH2 protein [161]

Regulation Mechanism

Transcription Factor Info

  Methadyl Acetate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Methadyl Acetate inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  Methapyrilene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Methapyrilene results in increased methylation of KCNH2 intron [126]

Regulation Mechanism

Transcription Factor Info

  methdilazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

methdilazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Methiothepin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Methiothepin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  methixene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

methixene results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  methylmercuric chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

methylmercuric chloride results in decreased expression of KCNH2 mRNA [195]

Regulation Mechanism

Transcription Factor Info

  methylselenic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

methylselenic acid results in increased expression of KCNH2 mRNA [196]

Regulation Mechanism

Transcription Factor Info

  mitemcinal

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

mitemcinal metabolite results in decreased activity of KCNH2 protein [197]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

mitemcinal results in decreased activity of KCNH2 protein [197]

Regulation Mechanism

Transcription Factor Info

  mitragynine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

mitragynine binds to and results in decreased activity of KCNH2 protein [88]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

mitragynine results in decreased expression of KCNH2 protein [88]

Regulation Mechanism

Transcription Factor Info

  mizolastine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

mizolastine results in decreased activity of KCNH2 protein [198]

Regulation Mechanism

Transcription Factor Info

  monorden

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

monorden results in decreased activity of KCNH2 protein [77]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

monorden results in decreased expression of KCNH2 protein modified form [77]

Regulation Mechanism

Transcription Factor Info

  N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction TGFB1 protein results in decreased expression of KCNH2 protein [199]

Regulation Mechanism

Transcription Factor Info

  nadifloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

nadifloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  naftifine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

naftifine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  naringenin

           9 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amiodarone promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

azimilide promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

dofetilide promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

naringenin promotes the reaction Amiodarone results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

naringenin promotes the reaction azimilide results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

naringenin promotes the reaction dofetilide results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

naringenin promotes the reaction Quinidine results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Quinidine promotes the reaction naringenin results in decreased activity of KCNH2 protein [81]

Regulation Mechanism

Transcription Factor Info

  nefazodone

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

nefazodone affects the activity of KCNH2 protein [200]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

nefazodone binds to and results in decreased activity of KCNH2 protein [201]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

nefazodone results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  nifekalant

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

nifekalant affects the activity of KCNH2 protein [129]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

nifekalant results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Niflumic Acid

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

E 4031 inhibits the reaction Niflumic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Niflumic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  niguldipine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

niguldipine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  nilotinib

           4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

N-butanoylsphingosine inhibits the reaction nilotinib results in decreased expression of KCNH2 protein modified form [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

nilotinib results in decreased activity of KCNH2 protein [53]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

nilotinib results in decreased expression of and results in decreased activity of KCNH2 protein [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

nilotinib results in decreased expression of KCNH2 protein modified form [57]

Regulation Mechanism

Transcription Factor Info

  nimesulide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

nimesulide results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  Nitrovin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nitrovin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Nonachlazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nonachlazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Norfloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Norfloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  norfluoxetine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

KCNH2 protein affects the susceptibility to norfluoxetine [186]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

norfluoxetine affects the localization of KCNH2 protein [186]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

norfluoxetine results in decreased activity of KCNH2 protein [186]

Regulation Mechanism

Transcription Factor Info

  Nortriptyline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nortriptyline inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  octoclothepine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

octoclothepine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Ofloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ofloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  oligomycin B

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

oligomycin B results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  o,p'-DDT

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

o,p'-DDT results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

o,p'-DDT results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  orbifloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

orbifloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  oxeladin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

oxeladin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  oxiconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

oxiconazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  oxymatrine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

oxymatrine inhibits the reaction Arsenic Trioxide results in decreased localization of KCNH2 protein [141]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

oxymatrine results in increased expression of KCNH2 protein [141]

Regulation Mechanism

Transcription Factor Info

  oxyphencyclimine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

oxyphencyclimine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Paliperidone Palmitate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Paliperidone Palmitate results in decreased activity of KCNH2 protein [202]

Regulation Mechanism

Transcription Factor Info

  panaxadiol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

panaxadiol affects the activity of KCNH2 protein [78]

Regulation Mechanism

Transcription Factor Info

  panaxatriol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

panaxatriol affects the activity of KCNH2 protein [78]

Regulation Mechanism

Transcription Factor Info

  Pefloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pefloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  pentanal

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pentanal results in increased expression of KCNH2 mRNA [87]

Regulation Mechanism

Transcription Factor Info

  perfluorooctanoic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perfluorooctanoic acid results in decreased expression of KCNH2 mRNA [205]

Regulation Mechanism

Transcription Factor Info

  Perhexiline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Perhexiline binds to KCNH2 protein [144]

Regulation Mechanism

Transcription Factor Info

  perhexiline maleate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perhexiline maleate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  periciazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

periciazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  perospirone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perospirone results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  phenothiazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

phenothiazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Phenylephrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phenylephrine affects the reaction KCNH2 protein results in increased transport of Potassium [121]

Regulation Mechanism

Transcription Factor Info

  pimobendan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pimobendan results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  piperacetazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

piperacetazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  piperidolate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

piperidolate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Pizotyline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pizotyline results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Potassium

         25 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Colforsin co-treated with 1-Methyl-3-isobutylxanthine results in increased activity of ADRB1 protein binds to ADRB2 protein affects the reaction KCNH2 protein results in increased transport of Potassium [121]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

E 4031 inhibits the reaction Flufenamic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

E 4031 inhibits the reaction Niflumic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Flufenamic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Fluoxetine inhibits the reaction KCNH2 protein results in increased transport of Potassium [187]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Gatifloxacin binds to and results in decreased activity of KCNH2 protein which results in decreased export of Potassium [151]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Hydroxychloroquine binds to and results in decreased activity of KCNH2 protein which results in decreased export of Potassium [151]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

iron(III)-ascorbic acid complex results in increased abundance of Reactive Oxygen Species affects the reaction KCNH2 protein affects the transport of Potassium [206]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

KCNH2 protein binds to KCNE2 protein which results in increased transport of Potassium [188]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

KCNH2 protein binds to KCNH2 protein which results in increased transport of Potassium [188]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

KCNH2 protein results in increased transport of Potassium [187]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

Niflumic Acid promotes the reaction KCNH2 protein results in increased transport of Potassium [184]

Regulation Mechanism

Transcription Factor Info

  DT Modulation13

Phenylephrine affects the reaction KCNH2 protein results in increased transport of Potassium [121]

Regulation Mechanism

Transcription Factor Info

  DT Modulation14

Potassium affects the reaction dofetilide analog inhibits the reaction dofetilide binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation15

Potassium affects the stability of and affects the localization of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation16

Potassium deficiency affects the folding of KCNH2 protein [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation17

Potassium inhibits the reaction Amiodarone results in decreased activity of KCNH2 protein [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation18

Potassium inhibits the reaction azimilide results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  DT Modulation19

Potassium inhibits the reaction dofetilide results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  DT Modulation20

Potassium inhibits the reaction Dronedarone results in decreased activity of KCNH2 protein [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation21

Potassium inhibits the reaction Gramicidin results in decreased expression of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  DT Modulation22

Potassium inhibits the reaction Quinidine results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  DT Modulation23

Potassium inhibits the reaction Sotalol results in decreased activity of KCNH2 protein [150]

Regulation Mechanism

Transcription Factor Info

  DT Modulation24

Potassium promotes the reaction Astemizole binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  DT Modulation25

Potassium promotes the reaction dofetilide binds to KCNH2 protein [146]

Regulation Mechanism

Transcription Factor Info

  prenylamine lactate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

prenylamine lactate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  pridinol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pridinol results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Procainamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Procainamide binds to and results in decreased activity of KCNH2 protein [130]

Regulation Mechanism

Transcription Factor Info

  profenamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

profenamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Proflavine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Proflavine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  propionaldehyde

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

propionaldehyde results in increased expression of KCNH2 mRNA [87]

Regulation Mechanism

Transcription Factor Info

  Propranolol

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Propranolol results in decreased activity of KCNH2 protein [39]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Propranolol results in decreased activity of KCNH2 protein binds to KCNE2 protein [188]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Propranolol results in decreased activity of KCNH2 protein binds to KCNH2 protein [188]

Regulation Mechanism

Transcription Factor Info

  proroxan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

proroxan results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  prosultiamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

prosultiamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  pyrathiazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pyrathiazine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  pyridine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pyridine analog binds to KCNH2 protein [208]

Regulation Mechanism

Transcription Factor Info

  Pyrilamine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pyrilamine affects the activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Pyrilamine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  pyrithione zinc

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pyrithione zinc results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Pyruvic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Pyruvic Acid inhibits the reaction Deoxyglucose co-treated with Glucose deficiency results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  pyrvinium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pyrvinium results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Quetiapine Fumarate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Quetiapine Fumarate inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Quetiapine Fumarate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  quifenadine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

quifenadine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  ractopamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ractopamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  rescinnamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

rescinnamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  rimcazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

rimcazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Ritanserin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ritanserin inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  Robenidine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Robenidine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Rolipram

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rolipram results in decreased activity of KCNH2 protein [41]

Regulation Mechanism

Transcription Factor Info

  Rose Bengal

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rose Bengal results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  rotigotine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

rotigotine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Rubidium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rubidium inhibits the reaction Gramicidin results in decreased expression of KCNH2 protein modified form [46]

Regulation Mechanism

Transcription Factor Info

  sarafloxacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sarafloxacin binds to KCNH2 protein [151]

Regulation Mechanism

Transcription Factor Info

  Semaxinib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Semaxinib results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  sertaconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sertaconazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  sertindole

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sertindole inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

sertindole results in decreased activity of KCNH2 protein [38]

Regulation Mechanism

Transcription Factor Info

  Simendan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Simendan results in decreased activity of KCNH2 protein [54]

Regulation Mechanism

Transcription Factor Info

  SM 21

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

SM 21 promotes the reaction ifenprodil results in decreased activity of KCNH2 protein [118]

Regulation Mechanism

Transcription Factor Info

  Sodium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium deficiency inhibits the reaction Digoxin results in decreased expression of KCNH2 protein [46]

Regulation Mechanism

Transcription Factor Info

  sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite affects the methylation of KCNH2 gene [211]

Regulation Mechanism

Transcription Factor Info

  Sodium Cyanide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium Cyanide inhibits the reaction Glucose results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  syrosingopine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

syrosingopine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  tazarotene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tazarotene results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  tecastemizole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tecastemizole binds to and results in decreased activity of KCNH2 protein [143]

Regulation Mechanism

Transcription Factor Info

  tenovin-1

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tenovin-1 results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Terbinafine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Terbinafine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  terconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

terconazole results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  terodiline

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

terodiline inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  tetramethrin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tetramethrin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  tetraoctylammonium bromide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tetraoctylammonium bromide results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

tetraoctylammonium bromide results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  Thallium

         72 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

2-(4-(2-(3,4-dichlorophenyl)ethyl)phenylamino)benzoic acid inhibits the reaction Terfenadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

2-(4-(2-(3,4-dichlorophenyl)ethyl)phenylamino)benzoic acid promotes the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a)quinoxalin-5(6H)-one inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Amiodarone inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Amitriptyline inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

amperozide inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Aripiprazole inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Astemizole inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Benzethonium results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

Bepridil inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

Chlorpheniramine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

Chlorpromazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation13

Ciclopirox inhibits the reaction Terfenadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation14

Ciclopirox promotes the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation15

Cisapride inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation16

Clomipramine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation17

Clozapine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation18

didecyldimethylammonium results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation19

diphenylguanidine results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation20

dofetilide inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation21

domiphen results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation22

Domperidone inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation23

Doxepin inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation24

Droperidol inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation25

E 4031 inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation26

Econazole results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation27

eliprodil inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation28

Fluoxetine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation29

Fluvoxamine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation30

Haloperidol inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation31

Imipramine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation32

KCNH2 protein results in increased import of Thallium [213]

Regulation Mechanism

Transcription Factor Info

  DT Modulation33

KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation34

KCNH2 results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation35

Lidoflazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation36

Loratadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation37

malachite green results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation38

Maprotiline inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation39

Mefloquine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation40

Methadyl Acetate inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation41

Mibefradil inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation42

N-(n-butyl)-(bis-fluorophenyl)methoxytropane inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation43

Nortriptyline inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation44

Olanzapine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation45

o,p'-DDT results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation46

Ouabain inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation47

Pentamidine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation48

Perphenazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation49

Phentolamine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation50

Pimozide inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation51

Propafenone inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation52

Pyrilamine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation53

Quetiapine Fumarate inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation54

Quinidine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation55

Quinidine results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation56

Reserpine results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation57

Risperidone inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation58

Ritanserin inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation59

sertindole inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation60

Tamoxifen inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation61

Tamoxifen results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation62

Terfenadine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation63

terodiline inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation64

tetraoctylammonium bromide results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation65

Thioridazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation66

Trifluoperazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation67

Trifluperidol inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation68

Tritolyl Phosphates results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation69

vanoxerine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation70

Verapamil inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation71

Verapamil results in decreased activity of KCNH2 protein which results in decreased import of Thallium [50]

Regulation Mechanism

Transcription Factor Info

  DT Modulation72

vinpocetine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  thiaton

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

thiaton results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  thiphenamil

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

thiphenamil results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  thonzonium bromide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

thonzonium bromide results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  tiamulin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tiamulin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  tipepidine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tipepidine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

trichostatin A results in decreased expression of KCNH2 mRNA [85]

Regulation Mechanism

Transcription Factor Info

  triethyl-(beta-4-stilbenoxyethyl)ammonium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

triethyl-(beta-4-stilbenoxyethyl)ammonium results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Trifluoperazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Trifluoperazine inhibits the reaction KCNH2 protein results in increased transport of Thallium [49]

Regulation Mechanism

Transcription Factor Info

  Trifluperidol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Trifluperidol inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  trimeprazine tartrate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

trimeprazine tartrate results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Tripelennamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tripelennamine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  triphenyl phosphate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

triphenyl phosphate affects the expression of KCNH2 mRNA [176]

Regulation Mechanism

Transcription Factor Info

  tri-xylenyl phosphate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tri-xylenyl phosphate results in decreased activity of KCNH2 protein [50]

Regulation Mechanism

Transcription Factor Info

  valnemulin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

valnemulin results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  vandetanib

           5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Brefeldin A promotes the reaction vandetanib results in decreased expression of KCNH2 protein modified form [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

N-butanoylsphingosine inhibits the reaction vandetanib results in decreased expression of KCNH2 protein modified form [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

vandetanib binds to KCNH2 protein [216]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

vandetanib results in decreased expression of and results in decreased activity of KCNH2 protein [57]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

vandetanib results in decreased expression of KCNH2 protein modified form [57]

Regulation Mechanism

Transcription Factor Info

  vanoxerine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

vanoxerine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  vapiprost

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

vapiprost results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  vesnarinone

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

KCNH2 gene SNP affects the susceptibility to vesnarinone [210]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

vesnarinone results in decreased activity of KCNH2 protein [210]

Regulation Mechanism

Transcription Factor Info

  vinpocetine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

vinpocetine inhibits the reaction KCNH2 protein results in increased transport of Thallium [131]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

vinpocetine results in decreased activity of KCNH2 protein [41]

Regulation Mechanism

Transcription Factor Info

  xaliproden

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

xaliproden results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  Xanthine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Xanthine co-treated with XDH protein results in decreased activity of KCNH2 protein [76]

Regulation Mechanism

Transcription Factor Info

  zatebradine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

zatebradine results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info

  ziprasidone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ziprasidone results in decreased activity of KCNH2 protein [56]

Regulation Mechanism

Transcription Factor Info
References
1 Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety. J Med Chem. 2005 Mar 24;48(6):1725-8.
2 Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5043-7.
3 Synthesis and pharmacological properties of a new hydrophilic and orally bioavailable 5-HT4 antagonist. Eur J Med Chem. 2013 Jun;64:629-37.
4 Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4633-7.
5 An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798). J Med Chem. 2011 Jan 13;54(1):67-77.
6 Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5303-8.
7 Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel. J Med Chem. 2007 Jun 28;50(13):2931-41.
8 Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior. J Med Chem. 2009 Jan 8;52(1):151-69.
9 Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptors. J Med Chem. 2010 Jun 24;53(12):4803-7.
10 Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4380-4.
11 Structure-activity relationships of 9-substituted-9-dihydroerythromycin-based motilin agonists: optimizing for potency and safety. J Med Chem. 2009 Nov 12;52(21):6851-9.
12 9-Dihydroerythromycins as non-antibiotic motilin receptor agonists. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5658-61.
13 Bioactive sulfoximines: syntheses and properties of Vioxx analogs. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4888-90.
14 Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4849-53.
15 Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation. Bioorg Med Chem Lett. 2012 Oct 1;22(19):6048-52.
16 Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens. J Med Chem. 2013 Mar 14;56(5):1974-83.
17 Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties. ACS Med Chem Lett. 2013 Sep 22;4(11):1037-41.
18 Design, synthesis and biological evaluation of isoquinoline-based derivatives as novel histone deacetylase inhibitors. Bioorg Med Chem. 2015 Sep 1;23(17):5881-90.
19 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists. J Med Chem. 2002 Jan 17;45(2):492-503.
20 Non-basic ligands for aminergic GPCRs: the discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3708-12.
21 An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. J Med Chem. 2006 Jun 1;49(11):3116-35.
22 Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. J Med Chem. 2006 Jul 13;49(14):4425-36.
23 Inhibitory effect of carboxylic acid group on hERG binding. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5507-12.
24 Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. Bioorg Med Chem Lett. 2013 Mar 15;23(6):1834-8.
25 Astemizole Derivatives as Fluorescent Probes for hERG Potassium Channel Imaging. ACS Med Chem Lett. 2016 Jan 20;7(3):245-9.
26 (3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1991-5.
27 Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2. Bioorg Med Chem Lett. 2009 Oct 15;19(20):5893-7.
28 Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine. J Med Chem. 2012 Dec 13;55(23):10644-51.
29 Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer's disease treatment. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3467-9.
30 Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy. J Med Chem. 2014 Aug 28;57(16):7016-30.
31 Discovery of orally bioavailable cyclohexanol-based NR2B-selective NMDA receptor antagonists with analgesic activity utilizing a scaffold hopping approach. Bioorg Med Chem Lett. 2017 Sep 1;27(17):4194-4198.
32 Inhibition of cardiac potassium currents by pentobarbital. Naunyn Schmiedebergs Arch Pharmacol. 2002 Jan;365(1):29-37.
33 Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG. Clin Sci (Lond). 2004 Aug;107(2):175-82.
34 Five novel single nucleotide polymorphisms in the CYP2C8 gene, one of which induces a frame-shift. Drug Metab Pharmacokinet. 2002;17(4):374-7.
35 Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology. 2005 Apr;74(1):31-6.
36 Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res. 2005 Jan;63(1):17-25.
37 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
38 Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J Pharmacol Exp Ther. 2006 Mar;316(3):1098-106.
39 Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy. Br J Pharmacol. 2006 Mar;147(6):642-52.
40 Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels. Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1059-65.
41 Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity. J Appl Toxicol. 2007 Jan-Feb;27(1):78-85.
42 Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome. Br J Pharmacol. 2008 Feb;153(3):439-47.
43 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31.
44 Effects of common antitussive drugs on the hERG potassium channel current. J Cardiovasc Pharmacol. 2008 Dec;52(6):494-9.
45 Hydroxyzine, a first generation H(1)-receptor antagonist, inhibits human ether-a-go-go-related gene (HERG) current and causes syncope in a patient with the HERG mutation. J Pharmacol Sci. 2008 Dec;108(4):462-71.
46 Intracellular potassium stabilizes human ether-?go-go-related gene channels for export from endoplasmic reticulum. Mol Pharmacol. 2009 Apr;75(4):927-37.
47 Block of HERG k channel by classic histamine h(1) receptor antagonist chlorpheniramine. Korean J Physiol Pharmacol. 2009 Jun;13(3):215-20.
48 Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian Cells. Arch Drug Inf. 2009 Sep;2(3):51-57.
49 Identification of human Ether-?go-go related gene modulators by three screening platforms in an academic drug-discovery setting. Assay Drug Dev Technol. 2010 Dec;8(6):727-42.
50 Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels. Toxicol Appl Pharmacol. 2011 May 1;252(3):250-8.
51 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
52 Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels. Exp Ther Med. 2011 May;2(3):481-486.
53 Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):245-55.
54 Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicol Sci. 2013 Dec;136(2):581-94.
55 Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia Cells. Biomark Insights. 2016 Aug 24;11:113-21.
56 Why are most phospholipidosis inducers also hERG blockers?. Arch Toxicol. 2017 Dec;91(12):3885-3895.
57 Downregulation of hERG channel expression by tyrosine kinase inhibitors nilotinib and vandetanib predominantly contributes to arrhythmogenesis. Toxicol Lett. 2022 Jul 15;365:11-23.
58 Drug interaction at hERG channel: In vitro assessment of the electrophysiological consequences of drug combinations and comparison against theoretical models. J Appl Toxicol. 2018 Apr;38(4):450-458.
59 Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential. Toxicol Sci. 2019 Apr 1;168(2):365-380.
60 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
61 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
62 Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol. 2018 Jan;92(1):371-381.
63 Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
64 The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2150-5.
65 Selenophene-containing inhibitors of type IIA bacterial topoisomerases. J Med Chem. 2011 May 12;54(9):3418-25.
66 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. J Med Chem. 2007 Dec 27;50(26):6450-3.
67 Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2179-85.
68 Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer. Bioorg Med Chem. 2010 Dec 1;18(23):8150-7.
69 Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorg Med Chem Lett. 2011 Jan 1;21(1):97-101.
70 Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors. J Med Chem. 2011 Jul 14;54(13):4752-72.
71 Optimization of propafenone analogues as antimalarial leads. J Med Chem. 2011 Nov 10;54(21):7477-85.
72 Wake-promoting agents: search for next generation modafinil: part I. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2312-4.
73 Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts. Bioorg Med Chem. 2012 Mar 15;20(6):2180-8.
74 Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives. J Med Chem. 2015 Apr 23;58(8):3411-31.
75 Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds. Eur J Med Chem. 2017 Jan 27;126:1129-1135.
76 Impairment of human ether-?go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem. 2003 Mar 21;278(12):10417-26.
77 Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res. 2003 Jun 27;92(12):e87-100.
78 Modulating effect of ginseng saponins on heterologously expressed HERG currents in Xenopus oocytes. Acta Pharmacol Sin. 2005 May;26(5):551-8.
79 Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses. Int J Environ Res Public Health. 2006 Jun;3(2):141-73.
80 Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assay. J Cardiovasc Pharmacol. 2007 May;49(5):269-74.
81 The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Cardiology. 2008;110(3):145-52.
82 Cyamemazine metabolites: effects on human cardiac ion channels in-vitro and on the QTc interval in guinea pigs. J Pharm Pharmacol. 2008 Nov;60(11):1507-13.
83 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
84 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
85 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
86 Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolimod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation. Toxicol Appl Pharmacol. 2014 Nov 15;281(1):39-47.
87 Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity. Toxicology. 2015 Aug 6;334:111-21.
88 Mitragynine and its potential blocking effects on specific cardiac potassium channels. Toxicol Appl Pharmacol. 2016 Aug 15;305:22-39.
89 Modulation of the heart's electrical properties by the anticonvulsant drug retigabine. Toxicol Appl Pharmacol. 2017 Aug 15;329:309-317.
90 Toxicogenomic study to identify potential signaling alterations related to nasal inflammatory damages induced by diesel exhaust particles in primary human nasal epithelial cells. Toxicol In Vitro. 2020 Dec;69:104994.
91 Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3788-92.
92 Emerging drugs for spinal cord injury. Expert Opin Emerg Drugs. 2008 Mar;13(1):63-80.
93 Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century. J Med Chem. 2009 Mar 12;52(5):1408-15.
94 Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82.
95 The discovery of novel calcium sensing receptor negative allosteric modulators. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3328-32.
96 Design, synthesis, and biological evaluation of 16-substituted 4-azasteroids as tissue-selective androgen receptor modulators (SARMs). J Med Chem. 2009 Aug 13;52(15):4578-81.
97 Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primates. J Med Chem. 2010 Feb 25;53(4):1774-87.
98 Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2634-8.
99 5-Functionalized indazoles as glucocorticoid receptor agonists. Bioorg Med Chem Lett. 2010 May 15;20(10):3017-20.
100 Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis. J Med Chem. 2010 Jun 10;53(11):4412-21.
101 Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3235-9.
102 Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituents. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4012-4.
103 Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38 MAP kinase inhibitor for the treatment of inflammatory diseases. J Med Chem. 2010 Sep 23;53(18):6629-39.
104 Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist. J Med Chem. 2010 Dec 9;53(23):8228-40.
105 Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases. Bioorg Med Chem Lett. 2011 Jan 1;21(1):288-93.
106 Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. J Med Chem. 2011 Jan 27;54(2):635-54.
107 Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease. J Med Chem. 2011 Nov 24;54(22):7797-814.
108 Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. J Med Chem. 2012 Feb 9;55(3):1082-105.
109 Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligands. J Med Chem. 2012 Nov 26;55(22):9446-66.
110 A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787. Bioorg Med Chem Lett. 2013 May 1;23(9):2663-70.
111 Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists. Bioorg Med Chem Lett. 2013 Dec 15;23(24):6890-6.
112 Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes. J Med Chem. 2014 Apr 24;57(8):3205-12.
113 Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator. ACS Med Chem Lett. 2013 Jan 4;4(3):333-7.
114 Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors. Eur J Med Chem. 2014 Nov 24;87:765-81.
115 Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms. ACS Med Chem Lett. 2015 Jul 12;6(8):850-5.
116 Saccharin Aza Bioisosteres-Synthesis and Preclinical Property Comparisons. ACS Med Chem Lett. 2017 May 1;8(6):672-677.
117 Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy. J Med Chem. 2017 Nov 9;60(21):8847-8857.
118 sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart. J Pharmacol Exp Ther. 2007;322(1):341-50.
119 Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of invivo assays in mice. Neuropharmacology. 2016;110(Pt A):143-153.
120 Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile. Toxicol Appl Pharmacol. 2013;273(2):259-68.
121 Adrenergic regulation of the rapid component of delayed rectifier K+ current: implications for arrhythmogenesis in LQT2 patients. Heart Rhythm. 2009;6(7):1038-46.
122 Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. Mol Pharmacol. 2005;68(3):876-84.
123 Acute alteration of cardiac ECG, action potential, I(Kr) and the human ether-a-go-go-related gene (hERG) K+ channel by PCB 126 and PCB 77. Toxicol Appl Pharmacol. 2012;262(1):60-9.
124 Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol. Toxicol Lett. 2020;319:40-48.
125 Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells. Toxicol Lett. 2019;312:1-10.
126 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018;121:214-223.
127 Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action. Naunyn Schmiedebergs Arch Pharmacol. 2004;370(6):423-35.
128 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
129 A mechanism underlying compound-induced voltage shift in the current activation of hERG by antiarrhythmic agents. Biochem Biophys Res Commun. 2011;415(1):141-6.
130 Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels. J Pharmacol Sci. 2004;95(3):311-9.
131 A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel. Anal Biochem. 2009;394(1):30-8.
132 Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. Naunyn Schmiedebergs Arch Pharmacol. 1999;359(3):212-9.
133 Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action. Br J Pharmacol. 2004;142(3):485-94.
134 Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. Toxicol In Vitro. 2021;70:105054.
135 Dual effects of arsenic trioxide on tumor cells and the potential underlying mechanisms. Oncol Lett. 2018;16(3):3812-3820.
136 The rescuable function and mechanism of resveratrol on As-induced hERG K channel deficiency. Naunyn Schmiedebergs Arch Pharmacol. 2014;387(11):1079-89.
137 Up-regulation of miR-21 and miR-23a Contributes to As2 O3 -induced hERG Channel Deficiency. Basic Clin Pharmacol Toxicol. 2015;116(6):516-23.
138 Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol. 2004;66(1):33-44.
139 Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism. Toxicol Sci. 2017;158(2):379-390.
140 Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci U S A. 2004;101(13):4578-83.
141 Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression. Biochem Pharmacol. 2013;85(1):59-68.
142 Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects. J Biol Chem. 1999;274(44):31123-6.
143 Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole. J Cardiovasc Electrophysiol. 1999;10(6):836-43.
144 Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-go-go-related gene channels. Mol Pharmacol. 2008;74(5):1443-52.
145 Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel. Eur J Pharmacol. 1999;374(3):457-60.
146 Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs. Toxicol Appl Pharmacol. 2014;274(1):78-86.
147 Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation. FEBS Lett. 2000;474(1):111-5.
148 Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels. Chem Res Toxicol. 2012;25(9):1975-84.
149 The influence of extracellular acidosis on the effect of IKr blockers. J Cardiovasc Pharmacol Ther. 2005;10(1):67-76.
150 The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. Cardiology. 2007;108(1):18-27.
151 Computational and experimental studies on the inhibitory mechanism of hydroxychloroquine on hERG. Toxicology. 2021;458:152822.
152 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017;8(1):1369-1391.
153 Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. Assay Drug Dev Technol. 2004;2(5):497-506.
154 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019;11(1):138.
155 Electrophysiological effects of brompheniramine on cardiac ion channels and action potential. Pharmacol Res. 2006;54(6):414-20.
156 Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. J Am Heart Assoc. 2018;7(7).
157 Antiarrhythmic drug carvedilol inhibits HERG potassium channels. Cardiovasc Res. 2001;49(2):361-70.
158 Identification of potential target genes of ROR-alpha in THP1 and HUVEC cell lines. Exp Cell Res. 2017;353(1):6-15.
159 Functional consequences of methionine oxidation of hERG potassium channels. Biochem Pharmacol. 2007;74(5):702-11.
160 Interactions at human ether-go-go-related gene channels. Toxicol Sci. 2010;114(2):346-55.
161 QTc interval prolongation associated with intravenous methadone. Pain. 2003;105(3):499-506.
162 Ionic mechanisms underlying cardiac toxicity of the organochloride solvent trichloromethane. Toxicology. 2011;290(2-3):295-304.
163 Block of HERG human K(+) channel and IKr of guinea pig cardiomyocytes by chlorpromazine. J Cardiovasc Pharmacol. 2004;43(5):706-14.
164 A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A. 2000;97(22):12329-33.
165 The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations. J Biol Chem. 2002;277(7):4989-98.
166 Human ether-go-go-related gene expression is essential for cisplatin to induce apoptosis in human gastric cancer. Oncol Rep. 2012;27(2):433-40.
167 MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97(2):175-87.
168 The hypoxia-mimetic agent cobalt chloride induces cell cycle arrest and alters gene expression in U266 multiple myeloma cells. Int J Mol Med. 2012;30(5):1180-6.
169 Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs. Eur J Pharmacol. 2006;532(3):270-8.
170 Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
171 Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells. Eur J Pharmacol. 2011;660(2-3):259-67.
172 Toxicology profile of a novel GLP-1 receptor biased agonist-SAL0112 in nonhuman primates. Toxicol Appl Pharmacol. 2024;492:117125.
173 Block of the human ether-a-go-go-related gene (hERG) K+ channel by the antidepressant desipramine. Biochem Biophys Res Commun. 2010;394(3):536-41.
174 Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells. PLoS One. 2012;7(12):e51550.
175 Allitridin reduces I Kr current by disrupting the trafficking of human ether-go-go-related gene channels. Cardiology. 2014;128(1):1-8.
176 Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60-69 Years of Age: Evidence from the China BAPE Study. Environ Health Perspect. 2023;131(4):47009.
177 Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. Br J Pharmacol. 2008;155(6):957-66.
178 A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data. Clin Pharmacol Ther. 2005;77(6):572-82.
179 Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects. Dig Dis Sci. 2011;56(1):115-24.
180 [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin]. Ai Zheng. 2005;24(8):924-9.
181 Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve. J Pharmacol Toxicol Methods. 2006;54(2):130-40.
182 Docking model of drug binding to the human ether-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach. J Med Chem. 2009;52(6):1630-8.
183 Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block. Circulation. 2002;105(24):2830-5.
184 Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes. Eur J Pharmacol. 2002;452(3):269-77.
185 Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity. Toxicol Lett. 2017;277:64-68.
186 Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br J Pharmacol. 2006;149(5):481-9.
187 The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J Pharmacol Exp Ther. 2002;300(2):543-8.
188 Effect of beta-adrenoceptor blockers on human ether-a-go-go-related gene (HERG) potassium channels. Basic Clin Pharmacol Toxicol. 2005;96(2):123-30.
189 Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656. FEBS Lett. 2006;580(8):1999-2005.
190 Blockade of HERG and Kv1.5 by ketoconazole. J Pharmacol Exp Ther. 1998 Aug;286(2):727-35.
191 Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs). Biochem Pharmacol. 2001;62(9):1229-38.
192 Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions. J Pharmacol Exp Ther. 2000;292(1):261-4.
193 Molecular Insights into hERG Potassium Channel Blockade by Lubeluzole. Cell Physiol Biochem. 2018;45(6):2233-2245.
194 Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator. J Biol Chem. 2004;279(14):13289-92.
195 Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
196 Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer. Cancer Genomics Proteomics. 2005;2(2):97-114.
197 Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin. J Toxicol Sci. 2007;32(3):217-30.
198 Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine. Br J Pharmacol. 2000;131(6):1081-8.
199 Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome. Cardiovasc Res. 2012;96(1):90-8.
200 Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2016 Apr 1;296:42-53.
201 A novel assessment of nefazodone-induced hERG inhibition by electrophysiological and stereochemical method. Toxicol Appl Pharmacol. 2014;274(3):361-71.
202 Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?. J Cardiovasc Pharmacol. 2011;57(6):690-5.
203 Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther. 2005;312(1):316-23.
204 Protein trafficking abnormalities: a new mechanism in drug-induced long QT syndrome. Br J Pharmacol. 2005;145(1):3-4.
205 Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. Arch Toxicol. 2022;97(2):457-68.
206 Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species. Proc Natl Acad Sci U S A. 1997;94(21):11698-703.
207 Trapping and dissociation of propafenone derivatives in HERG channels. Br J Pharmacol. 2011;162(7):1542-52.
208 Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity. Bioorg Med Chem Lett. 2007;17(20):5533-6.
209 Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol. 2005;16(1):54-8.
210 Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. Mol Pharmacol. 2003;63(5):1051-8.
211 Microarray dataset of transient and permanent DNA methylation changes in HeLa cells undergoing inorganic arsenic-mediated epithelial-to-mesenchymal transition. Data Brief. 2017;13:6-9.
212 Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations. Toxicol Appl Pharmacol. 2011;257(1):74-83.
213 Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-go-go related gene potassium channels. Assay Drug Dev Technol. 2010;8(6):743-54.
214 Effect of trazodone on hERG channel current and QT-interval. Eur J Pharmacol. 2005;510(1-2):75-85.
215 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.
216 Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes. PLoS One. 2018;13(4):e0195577.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.